title: Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: K
authors.initials: K
authors.lastname: Noguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshida
authors.forename: A
authors.initials: A
authors.lastname: Yagihashi
authors.forename: Y
authors.initials: Y
authors.lastname: Kita
authors.forename: T
authors.initials: T
authors.lastname: Takenaka
authors.forename: K
authors.initials: K
authors.lastname: Terasawa
authors.forename: S
authors.initials: S
authors.lastname: Hayashi
authors.forename: A
authors.initials: A
authors.lastname: Konno
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
authors.forename: K
authors.initials: K
authors.lastname: Nakamura
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D007421:Intestine, Small / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D015166:Monitoring, Immunologic / Q000379:methods; D014184:Transplantation, Homologous / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
chemical_list: D015415:Biomarkers; D007376:Interleukin-2; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D008776:Methylprednisolone Hemisuccinate